Lymphocytoma cutis, or benign reactive lymphoid hyperplasia, is an inflammatory skin lesion that mimics clinically and histologically malignant lymphoma. Most cases are idiopathic, but they may also be triggered by multiple factors, such as insect bites, tattoos, injections and herpes zoster. Clinically, the lesions are erythematous, soft papules, plaques or nodules, usually located on the upper limbs and face. The diagnosis is mainly based on histopathology and immunohistochemistry. Corticosteroid injections, cryosurgery, PUVA therapy, radiotherapy and surgery can be therapeutic options in cases requiring immediate treatment. To demonstrate an atypical presentation of this tumor, a case lymphocytoma skin on the groin will be reported, describing its diagnosis and treatment.
Lymphocytoma cutis, or benign reactive lymphoid hyperplasia, is an inflammatory skin lesion that mimics clinically and histologically malignant lymphoma. Most cases are idiopathic, but they may also be triggered by multiple factors, such as insect bites, tattoos, injections and herpes zoster. Clinically, the lesions are erythematous, soft papules, plaques or nodules, usually located on the upper limbs and face. The diagnosis is mainly based on histopathology and immunohistochemistry. Corticosteroid injections, cryosurgery, PUVA therapy, radiotherapy and surgery can be therapeutic options in cases requiring immediate treatment. To demonstrate an atypical presentation of this tumor, a case lymphocytoma skin on the groin will be reported, describing its diagnosis and treatment.
Lymphocytoma cutis, benign reactive lymphoid hyperplasia, or Spiegler-Fendt
pseudolymphomas are inflammatory lesions that mimic malignant lymphoma clinically
and histologically. They are a rare condition with higher incidence in Caucasian,
young (before 40 years of age) females (3:1 ratio).[1,2]Lymphocytoma cutis is classified according to its lymphoid population, dermal
infiltration pattern and associated clinical findings. In 1980, Burg and Braun-Falco
proposed a classification based in the architecture of the cutaneous infiltrate,
dividing them in T-cell and B-cell models. The T-cell model is characterized by a
dense infiltrate in the upper dermis, mimicking mycosis fungoides. This group
includes actinic reticuloid, lymphomatoid contact dermatitis and lymphomatoid drug
eruption. The B-cell model presents with a nodular infiltrate all through the
dermis, as seen in malignant cutaneous B-cell lymphomas. This group includes
lymphocytoma cutis, Jessner’s lymphocytic infiltration and some insect bite
reactions.[3]Most cases are idiopathic, but lesions may be triggered by multiple factors - such as
insect bites, vaccinations, acupuncture, piercings, traumas, tattoos, injections,
herpes zoster scars, HIV, drugs, contact with certain allergens, purpuric lichenoid
dermatitis, lichen sclerosus et atrophicus, secondary syphilis, inflammatory
morphea, Borrelia burgdorferi, Leishmania donovani or molluscum
contagiosum -, that have in common the generation of a more intense lymphocytic
reaction in the skin. The most frequently associated drugs are phenytoin,
angiotensin converting enzyme inhibitors, antihistamines and, less frequently,
bromocriptine and cefuroxime. The lesions are mainly located on the face and upper
limbs.[2-4]Clinically, the lesions appear as soft, erythematous papules, plaques or
nodules.[5]The diagnosis is based on histopathology, clinical features and patient follow-up.
The condition is chronic, but is benign and asymptomatic, tending to spontaneous
resolution without residual scarring.[6,7]Considering the challenging and important differential diagnosis, the objective of
this study was to report a case of a patient with lymphocytoma cutis on the inguinal
region.
CASE REPORT
A 16-year-old female patient, student, born and resident in Teresina (PI, Brazil),
sought medical assistance due to the presence of papules that started to coalesce
into a linear, papillomatous tumor on the right inguinal region over the past 2
years (Figure 1).
Figure 1
Lymphocytoma cutis (linear papillomatous lesion) on the right inguinal
region
Lymphocytoma cutis (linear papillomatous lesion) on the right inguinal
regionAccording to the patient, the lesion was asymptomatic, non-bleeding, and she could
not identify triggering factors nor comorbidities. Histopathology revealed a dense,
heterogenous lymphomononuclear inflammatory infiltrate, with lymphoid follicles with
reactive features and preserved epidermis (Figures
2 and 3).
Figure 2
Detail of the lymphoid infiltrate with preserved epidermis (Hematoxylin
& eosin, X200)
Figure 3
Nodular lymphoid infiltrate with germinal center (Hematoxylin &
eosin, X200)
Detail of the lymphoid infiltrate with preserved epidermis (Hematoxylin
& eosin, X200)Nodular lymphoid infiltrate with germinal center (Hematoxylin &
eosin, X200)The histological findings suggested lymphocytoma cutis, however, complementary
immunohistochemistry was performed for better assessment. Immunohistochemistry
revealed a mixed population of B lymphocytes (CD20) and T lymphocytes (CD3) (Figures 4 and 5).
Figure 4
B lymphocyte infiltrate (CD20) on immunohistochemistry
Figure 5
T lymphocyte infiltrate (CD3) on immunohistochemistry
B lymphocyte infiltrate (CD20) on immunohistochemistryT lymphocyte infiltrate (CD3) on immunohistochemistryThe immunohistochemistry’s conclusion was of a cutaneous lymphoid infiltrate with the
following features: 1) heterogenous lymphoid infiltrate with preserved epidermis,
occupying predominantly the superficial dermis in a nodular configuration; 2) mixed
inflammatory infiltrate with frequent inflammatory cells including plasma cells,
macrophages, eosinophils and multinucleated giant cells (Figure 6).
Figure 6
Mixed lymphoid infiltrate with inflammatory cells, including plasma
cells, macrophages, eosinophils and multinucleated giant cells
(Hematoxylin & eosin, X1000)
Mixed lymphoid infiltrate with inflammatory cells, including plasma
cells, macrophages, eosinophils and multinucleated giant cells
(Hematoxylin & eosin, X1000)The association of the morphological features with the immunohistochemical profile
favored the diagnosis of lymphocytoma cutis. The patient was referred for surgical
excision, with no follow-up.
DISCUSSION
Lymphocytoma cutis can be either localized, the most common form, or
disseminated.[8] The reported
case demonstrated the localized form with a unique presentation: papillomatous,
linear, soft, non-scaly, erythematous and varying in diameter (7cm to 10cm).Lymphocytoma cutis is traditionally subdivided into “exclusively B-cells” and
“exclusively T-cells”, however, the majority of lesions also have histiocytes. In
some cases, there are plasma cells and eosinophils, such as in our case. On
histopathology, it is characterized by a mixed, nodular or diffuse infiltrate in the
papillary and reticular dermis. In this case, there was involvement of the
superficial dermis in a nodular configuration and preservation of the
epidermis.[7,10]The differential diagnosis can be made with angiolymphoid hyperplasia, sarcoid,
mycosis fungoides, polymorphous light eruption and cutaneous lymphoma. The latter is
the main differential diagnosis, given the different biological behavior, prognosis
and therapeutic implications. The differentiation between lymphocytoma cutis and
cutaneous lymphoma can be done through a clinical, histological and
immunohistochemical analysis. The demonstration of a monoclonal expression of light
chains or the absence of detectable immunoglobulin in tumor samples are typical of
cutaneous B-cell lymphoma and represent the most important criteria for its
diagnosis. An accurate diagnosis of these lesions is necessary to guide treatment
and for a proper prognosis. Importantly, in sporadic cases, there is possibility of
the appearance of a cutaneous lymphoma in the same areas where lymphocytoma cutis
was previously diagnosed. Cutaneous lymphoma has a worse prognosis and treatment
response.[1,7]A broad analysis allows the classification of this case as idiopathic lymphocytoma
cutis, according to the history clinical aspect, histopathology and
immunohistochemistry.[2]There is some controversy in literature regarding treatment. Corticosteroid
injections, cryosurgery, PUVA therapy, radiotherapy and surgery can be therapeutic
options in cases needing immediate treatment. In our case, the patient was treated
with surgery.[3,6]
Authors: Jose Antonio Plaza; Nneka I Comfere; Lawrence E Gibson; Michael Colgan; Dawn Marie R Davis; Mark R Pittelkow; Joseph P Colgan Journal: J Am Acad Dermatol Date: 2009-05 Impact factor: 11.527
Authors: Lorenzo Cerroni; Riccardo G Borroni; Cesare Massone; Andreas Chott; Helmut Kerl Journal: Am J Dermatopathol Date: 2007-12 Impact factor: 1.533